CGU finds irregularities in drug sales from Farmácia Popular between 2015 and 2020

Here is a summary of the document in a concise manner:

Summary:

The Controladoria-Geral da Uniu00e3o (CGU) has concluded an audit on establishments enrolled in the Farmu00e1cia Popular do Brasil (PFPB) program, covering the period from 2015 to 2020. The audit found that over R$ 2.5 billion in sales records (18.53% of the total) submitted to the Ministry of Health (MS) lacked proof of purchase invoices, which is considered an irregular practice and punishable by penalties, such as returning the funds to the public treasury, fines, and program de-crediting. Additionally, the audit identified sales of medicines made after the beneficiary's death, resulting in a total loss of R$ 7.4 million.

The CGU recommends elaborating a risk-based treatment plan, applying sanctions, and strengthening controls within the program to prevent such incidents. The Ministry of Health and the CGU are working together to improve the program's security and prevent any type of deviation or misuse.